全文获取类型
收费全文 | 15976篇 |
免费 | 1099篇 |
国内免费 | 501篇 |
专业分类
耳鼻咽喉 | 100篇 |
儿科学 | 263篇 |
妇产科学 | 258篇 |
基础医学 | 1332篇 |
口腔科学 | 538篇 |
临床医学 | 2120篇 |
内科学 | 2814篇 |
皮肤病学 | 254篇 |
神经病学 | 806篇 |
特种医学 | 320篇 |
外国民族医学 | 1篇 |
外科学 | 1573篇 |
综合类 | 1823篇 |
现状与发展 | 3篇 |
预防医学 | 759篇 |
眼科学 | 107篇 |
药学 | 3506篇 |
6篇 | |
中国医学 | 576篇 |
肿瘤学 | 417篇 |
出版年
2023年 | 301篇 |
2022年 | 535篇 |
2021年 | 759篇 |
2020年 | 593篇 |
2019年 | 513篇 |
2018年 | 475篇 |
2017年 | 457篇 |
2016年 | 418篇 |
2015年 | 509篇 |
2014年 | 788篇 |
2013年 | 1057篇 |
2012年 | 782篇 |
2011年 | 913篇 |
2010年 | 685篇 |
2009年 | 596篇 |
2008年 | 617篇 |
2007年 | 669篇 |
2006年 | 546篇 |
2005年 | 462篇 |
2004年 | 451篇 |
2003年 | 389篇 |
2002年 | 322篇 |
2001年 | 282篇 |
2000年 | 264篇 |
1999年 | 223篇 |
1998年 | 214篇 |
1997年 | 220篇 |
1996年 | 203篇 |
1995年 | 214篇 |
1994年 | 200篇 |
1993年 | 185篇 |
1992年 | 166篇 |
1991年 | 178篇 |
1990年 | 195篇 |
1989年 | 171篇 |
1988年 | 143篇 |
1987年 | 147篇 |
1986年 | 153篇 |
1985年 | 201篇 |
1984年 | 188篇 |
1983年 | 135篇 |
1982年 | 203篇 |
1981年 | 129篇 |
1980年 | 134篇 |
1979年 | 97篇 |
1978年 | 75篇 |
1977年 | 90篇 |
1976年 | 71篇 |
1975年 | 63篇 |
1974年 | 47篇 |
排序方式: 共有10000条查询结果,搜索用时 0 毫秒
31.
Cyclic hormonal replacement therapy after the menopause: Transdermal versus oral treatment 总被引:2,自引:0,他引:2
M. Cortellaro T. Nencioni C. Boschetti S. Ortolani F. Buzzi B. Francucci M. P. Caraceni P. Abelli F. Polvani C. Zanussi 《European journal of clinical pharmacology》1991,41(6):555-559
Summary In an open, randomized, comparative, between-patient trial, 45 postmenopausal women were treated for 4 months with cyclical transdermal oestradiol 0.05 mg per day or oral conjugated equine oestrogens 0.625 mg per day, in both cases, plus, medroxyprogesterone acetate 10 mg per day on the last 8 days of each cycle. Similar relief from postmenopausal symptoms was obtained with both treatments. Post-treatment histological evaluation of the endometrium did not reveal neoplastic or hyperplastic change in any patient.Early follicular-phase plasma oestradiol levels were observed only after transdermal oestradiol. There was a significant reduction in serum total cholesterol and LDL cholesterol in both treatment groups, with no difference between treatments, whereas serum triglyceride levels were decreased only by transdermal oestradiol. Plasma calcium and phosphorus fell significantly and serum intact parathyroid hormone rose significantly, with no difference between the therapies. No significant changes were observed in clotting factors.Transdermal oestradiol appears to be an effective and safe hormonal replacement therapy, and this route of administration may be responsible for the more useful action of the drug on serum lipids and plasma oestradiol levels. 相似文献
32.
In the past few years there have been numerous publications which have stressed the value of the dexamethasone suppression test (DST) as a diagnostic marker of endogenous depression. Our own studies in 333 psychiatric inpatients and 121 healthy subjects did not reveal a differential diagnostic use for the DST. This result is in good agreement with other results in the literature. Our data demonstrate that intervening variables such as severity of illness, weight loss, sleep disturbances, situational stress, drug and alcohol withdrawal, and the pharmacokinetics of dexamethasone have an important influence on DST results, regardless of the diagnostic classification. 相似文献
33.
鼻内镜下等离子低温射频治疗常年性变应性鼻炎的临床观察 总被引:2,自引:1,他引:1
目的探讨鼻内镜下等离子低温射频治疗常年性变应性鼻炎(PAR)的疗效及其优越性。方法在鼻内镜下用等离子低温射频治疗PAR48例,按照海口会议修订的“过敏性鼻炎诊断和疗效评定标准”,用计分法分别评定其疗效。结果该组48例术后随访半年进行评价,其中显效27.1%(13/48),有效58.3%(28/48),无效14.6%(7/48),总有效率为85.4%。疗效评分显示治疗前平均总分为(9.58±1.69)分,治疗后为(5.63±1.15)分(P<0.05)。结论鼻内镜下等离子低温射频烧灼筛前神经终末区域治疗PAR,具有简便、安全等优点,短期效果显著,特别适用于临床上应用抗组胺类药物及鼻内应用糖皮质激素治疗效果不甚理想及由于各种原因不能长期接受抗组胺类药物及鼻内应用糖皮质激素治疗的患者;但长期疗效有待进一步研究。 相似文献
34.
35.
36.
Alpha-glucosidase activity and sperm motility 总被引:2,自引:0,他引:2
We correlated the activity of alpha-glucosidase in seminal plasma with the motility and differential motility of sperm. Significant positive correlations were found between the alpha-glucosidase activity and both motility and the percentage sperm with good forward progression. This supports the use of alpha-glucosidase in semen as a marker of epididymal function and specifically of the development of motility. 相似文献
37.
高效液相色谱法测定微量耳血中头孢他定的浓度 总被引:2,自引:0,他引:2
本文介绍采取微量耳血以高效液相色谱法测定头孢他定(Ceftazidime)的血药浓度。血样经6%高氯酸沉淀蛋白,流动相为含25%甲醇的0.05mol/L醋酸铵溶液,以冰醋酸调节pH值至4~5,检测波长为254nm,内标物为头孢唑啉(Cefazolin)。经对家兔采取微量耳血测定其血药浓度,可知头孢他定为二室模型,T_1/2α为0.18±0.05h,T_1/2β为1.75±0.07h。并对3名住院病人静脉注射1g头孢他定后定时分别取微量耳血进行分析,所得结果与文献基本一致。本文方法简便、快速,结果令人满意。 相似文献
38.
39.
J. W. P. GOVERS-RIEMSLAG M. SMID J. A. COOPER† K. A. BAUER‡ R. D. ROSENBERG‡ C. E. HACK§ K. HAMULYAK¶ H. M. H. SPRONK G. J. MILLER† H. TEN CATE 《Journal of thrombosis and haemostasis》2007,5(9):1896-1903
BACKGROUND: The plasma kallikrein-kinin system (PKKS) has been implicated in cardiovascular disease, but activation of the PKKS has not been directly probed in individuals at risk of coronary heart disease (CHD) or stroke. OBJECTIVE: To determine the involvement of the PKKS, including factor XI, in cardiovascular disease occurring in a nested case-control study from the Second Northwick Park Heart Study (NPHS-II). METHODS AND RESULTS: After a median follow-up of 10.7 years, 287 cases of CHD and stroke had been recorded and 542 age-matched controls were selected. When FXIIa-C1 esterase inhibitor (C1-inhibitor) concentrations were divided into tertiles (lowest tertile as reference), the odds ratios (ORs) at 95% CIs for CHD were 0.52 (0.34-0.80) in the middle tertile and 0.73 (0.49-1.09) in the highest tertile (P = 0.01 for the overall difference; P = 0.01 for CHD and stroke combined). For kallikrein-C1-inhibitor complexes, the ORs for stroke were 0.29 (0.12-0.72) and 0.67 (0.30-1.52) in the middle and high tertiles, respectively (P = 0.02). FXIIa-C1-inhibitor and kallikrein-C1-inhibitor complexes were negatively related to smoking and fibrinogen (P < 0.005). FXIa-inhibitor complexes correlated strongly with FXIIa-inhibitor complexes. CONCLUSIONS: Lower levels of inhibitory complexes of the PKKS enzymes and particularly of FXIIa contribute to the risk of CHD and stroke in middle-aged men. This observation supports the involvement of the PKKS in atherothrombosis. 相似文献
40.
E. J. Ramos H. S. Pollinger M. D. Stegall J. M. Gloor A. Dogan J. P. Grande 《American journal of transplantation》2007,7(2):402-407
Rituximab, intravenous immunoglobulin (IVIG) and rabbit antithymocyte globulin (rATG) all have been suggested to have an effect on antibody producing cells, however, supporting data are lacking. To assess the impact of these agents on splenic B‐cell populations in vivo, we retrospectively examined 25 spleens removed from patients treated with these agents as part of desensitization protocols in either ABO incompatible or positive crossmatch living donor kidney transplantation. These were compared to control (CTL) spleens removed for trauma. CTLs and spleens removed at transplant after multiple pretransplant plasmaphereses (PP) plus low‐dose IVIG showed similar large numbers of naïve B cells (CD20+ and CD79+), plasma cells (CD138+) and memory B cells (CD27+ cells). Adding rituximab to this PP/IVIG regimen reduced the number naïve B cells, but had no effect on memory or plasma cells. Combination treatment (PP/IVIG, rituximab and rATG) showed a trend toward the reduction of CD27+ cells, but again plasma cells were unchanged. We conclude that none of these protocols reduces splenic plasma cells in vivo. PP/low‐dose IVIG does not alter splenic B cells, but the addition of rituximab decreases mature B cells. Memory B cells may be affected by combination therapy including rATG and requires further study. 相似文献